SCHEMBL6718482

SCHEMBL6718482

CCCN1CCC(c2cc(NC(=O)N3CCN(c4ccc(OC)c(OC)c4)CC3)ccc2OC)CC1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ MAPT P10636 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ HTR1A P08908 8/20 0.52
▸ HTR1D P28221 8/20 0.52
▸ HTR1B P28222 8/20 0.52
▸ HTR2A P28223 5/20 0.52
▸ HTR2C P28335 4/20 0.52
▸ HTR6 P50406 3/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ NAMPT P43490 1/20 0.48
▸ DRD2 P14416 1/20 0.47
▸ FAAH O00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714894 0.92 HTR1A (0.49) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6714739 0.92 HTR1A (0.62) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6717572 0.91 MAPT (0.55) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6724729 0.91 HTR1A (0.52) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6717901 0.90 HTR1A (0.62) SMN1; SMN2NPSR1MAPTALDH1A1KMT2A
SCHEMBL6718830 0.90 SMN1; SMN2 (0.49) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6720302 0.90 HTR1A (0.55) SMN1; SMN2NPSR1MAPTMEN1ALDH1A1
SCHEMBL6716503 0.90 HTR1A (0.53) SMN1; SMN2NPSR1MAPTMEN1KMT2A
SCHEMBL6714953 0.90 CA12 (0.53) SMN1; SMN2NPSR1MAPTALDH1A1HTR1A
SCHEMBL6718259 0.89 PDGFRB (0.51) SMN1; SMN2MAPTMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313477-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-03-03 — — EP claimed
EP-1313477-A1 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2003-05-28 — — EP claimed
WO-2002005819-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2002-01-24 — — WO claimed
EP-1313477-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-03-03 — — EP disclosed
EP-1313477-A1 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2003-05-28 — — EP disclosed
WO-2002005819-A1 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2002-01-24 — — WO disclosed
Send feedback